01 March 1999
Urokinase plasminogen activator (u-PA) versus selected parameters of fibrinolysis in the blood of patients with renal carcinoma
Izabela Iwan-Ziętek, Zbigniew ZiętekMed Sci Monit 1999; 5(2): CR233-238 :: ID: 505093
Abstract
The process of fibrinolysis was investigated in 100 patients with renal carcinoma, on the basis of the concentration of urokinase plasminogen activator (uPA), the level of plasmin/antiplasmin complexes (complexes PAP) and the concentration of α2,-antiplasmin (α2,-AP). Additionally, euglobulin lysis time (ELT), the level of fibrin and fibrinogen degradation products (FDP) and the concentration of fibrinogen were determined. Mean concentration of antigen and activity of uPA was much higher in patients with renal carcinoma than in subjects from control group. Likewise, the level of PAP complexes was higher, while there were no significant differences in the activity of α2,-AP. Euglobulin lysis time was shorter in patients with renal carcinoma. The level of FDP was also higher while the concentration of fibrinogen did not differ significantly when compared with control group. Shorter ELT time in patients with renal cancer is the evidence for greater activation of fibrinolysis. Elevated level of PAP complexes reflects increased plasmin generation through the conversion from plasminogen as a result of higher concentrations of urokinase plasminogen activator. Increased FDP level in patients with renal carcinoma is the result of higher fibrin degradation by generated plasmin. Normal level of α2,-AP in patients with renal carcinoma is the evidence for the efficiency of mechanisms controlling fibrinolysis activation, which prevent from the development of haemorrhagic diathesis in the course of uncontrolled activation of fibrinolysis. Investigated parameters of fibrinolysis were analysed depending on the advancement of renal carcinoma. It was demonstrated that the concentration of antigen and activity of uPA, as well as the level of PAP complexes increases along with the advancement of neoplasm. This proves that the advancement of renal cancer and the increase of its mass are accompanied by stronger activation of fibrinolysis caused by increased uPA release from neoplastic cells and the endothelium of pathological vessels. The results obtained indicate that the increase of uPA level is responsible for the elevation of fibrinolytic activity in the plasma of patients with renal carcinoma. uPA comes from neoplastic cells and the endothelium of pathological vessels. Increased fibrinolytic activity carries the risk of the development of haemorrhagic diathesis.
Keywords: renal carcinoma, urokinase plasminogen activator, Fibrinolysis
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952